SULT1A1
SULT1A1
Sulfotransferase 1A1 (SULT1A1) is an enzyme that in humans is encoded by the SULT1A1 gene. This enzyme belongs to the family of sulfotransferases, which are responsible for the sulfation of various molecules, including hormones, neurotransmitters, drugs, and xenobiotic compounds. Sulfation is a crucial phase II metabolic process that enhances the solubility of compounds, facilitating their excretion from the body.
Structure[edit]
SULT1A1 is a cytosolic enzyme that is predominantly expressed in the liver, but it is also found in other tissues such as the intestine, lung, and brain. The enzyme is composed of a single polypeptide chain and functions as a homodimer. Each monomer of SULT1A1 contains a PAPS (3'-phosphoadenosine-5'-phosphosulfate) binding site, which is essential for its sulfotransferase activity.
Function[edit]
SULT1A1 catalyzes the transfer of a sulfonate group from PAPS to a hydroxyl or amine group of a substrate, resulting in the formation of a sulfated product. This reaction is important for the metabolism and detoxification of endogenous compounds such as estrogens and thyroid hormones, as well as exogenous compounds including drugs and environmental toxins.
Clinical Significance[edit]
Variations in the SULT1A1 gene can lead to differences in enzyme activity among individuals, affecting drug metabolism and response. Polymorphisms in SULT1A1 have been associated with altered risk for certain diseases, including breast cancer and endometrial cancer. Understanding these genetic variations is important for pharmacogenomics and personalized medicine.
Research and Applications[edit]
SULT1A1 is a subject of ongoing research due to its role in drug metabolism and its potential impact on drug efficacy and toxicity. Studies are focused on understanding the enzyme's substrate specificity, regulation, and the effects of genetic polymorphisms on its activity.
Also see[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
